Jackson Creek Investment Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$763K Sell
3,319
-779
-19% -$162K 0.25% 174
2026
Q1
$866K Sell
4,098
-59
-1% -$12.7K 0.26% 168
2025
Q4
$854K Buy
4,157
+1,426
+52% +$268K 0.25% 167
2025
Q3
$429K Sell
2,731
-196
-7% -$30.3K 0.12% 224
2025
Q2
$492K Sell
2,927
-246
-8% -$36.5K 0.13% 227
2025
Q1
$437K Sell
3,173
-210
-6% -$26.8K 0.14% 242
2024
Q4
$400K Buy
+3,383
New +$395K 0.12% 254
2024
Q2
Sell
-5,874
Closed -$657K 307
2024
Q1
$657K Sell
5,874
-319
-5% -$34.4K 0.23% 218
2023
Q4
$624K Sell
6,193
-431
-7% -$42.8K 0.24% 210
2023
Q3
$575K Sell
6,624
-356
-5% -$32.2K 0.24% 209
2023
Q2
$660K Sell
6,980
-1,226
-15% -$104K 0.26% 193
2023
Q1
$620K Buy
+8,206
New +$619K 0.26% 206

Other funds holding CAH

Jackson Creek Investment Advisors's CAH Position: Q2 2026 in Review

Jackson Creek Investment Advisors reduced its Cardinal Health (CAH) stake by 19% in Q2 2026, selling an estimated $162K and leaving 3,319 shares worth $763K. The position accounts for 0.25% of the portfolio, ranked #174.

Jackson Creek Investment Advisors first reported a position in CAH in Q1 2023 and has held it in 12 quarters since. The position peaked at $866K in Q1 2026. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Jackson Creek Investment Advisors held 3,319 shares of Cardinal Health worth $763K as of Q2 2026.
  • Jackson Creek Investment Advisors sold 779 Cardinal Health shares in Q2 2026, an estimated $162K.
  • Cardinal Health made up 0.25% of Jackson Creek Investment Advisors's portfolio in Q2 2026, its #174 holding.
  • Jackson Creek Investment Advisors first reported a position in Cardinal Health in Q1 2023 and has held it in 12 quarters since.
  • Jackson Creek Investment Advisors's Cardinal Health position peaked at $866K in Q1 2026.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.